栄研化学の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/05/23 | 1,579 | 1,603 | 1,577 | 1,588 | +14 | +0.9% | 121,300 |
2023/05/22 | 1,563 | 1,579 | 1,554 | 1,574 | +9 | +0.6% | 105,300 |
2023/05/19 | 1,558 | 1,572 | 1,556 | 1,565 | +9 | +0.6% | 76,500 |
2023/05/18 | 1,554 | 1,558 | 1,546 | 1,556 | +1 | +0.1% | 93,200 |
2023/05/17 | 1,570 | 1,574 | 1,550 | 1,555 | -23 | -1.5% | 77,300 |
2023/05/16 | 1,578 | 1,581 | 1,568 | 1,578 | +11 | +0.7% | 63,700 |
2023/05/15 | 1,570 | 1,574 | 1,555 | 1,567 | +5 | +0.3% | 80,600 |
2023/05/12 | 1,573 | 1,576 | 1,554 | 1,562 | -12 | -0.8% | 67,100 |
2023/05/11 | 1,576 | 1,593 | 1,571 | 1,574 | -2 | -0.1% | 81,900 |
2023/05/10 | 1,585 | 1,587 | 1,568 | 1,576 | -18 | -1.1% | 135,200 |
2023/05/09 | 1,569 | 1,594 | 1,569 | 1,594 | +24 | +1.5% | 65,700 |
2023/05/08 | 1,561 | 1,579 | 1,555 | 1,570 | +7 | +0.4% | 69,700 |
2023/05/02 | 1,571 | 1,580 | 1,546 | 1,563 | -16 | -1% | 112,600 |
2023/05/01 | 1,586 | 1,590 | 1,564 | 1,579 | +2 | +0.1% | 123,000 |
2023/04/28 | 1,562 | 1,580 | 1,562 | 1,577 | +29 | +1.9% | 121,300 |
2023/04/27 | 1,550 | 1,555 | 1,542 | 1,548 | -8 | -0.5% | 97,900 |
2023/04/26 | 1,571 | 1,575 | 1,555 | 1,556 | -21 | -1.3% | 58,000 |
2023/04/25 | 1,578 | 1,589 | 1,573 | 1,577 | -3 | -0.2% | 59,700 |
2023/04/24 | 1,579 | 1,594 | 1,573 | 1,580 | +11 | +0.7% | 52,100 |
2023/04/21 | 1,570 | 1,576 | 1,563 | 1,569 | +1 | +0.1% | 42,500 |
2023/04/20 | 1,569 | 1,576 | 1,558 | 1,568 | -5 | -0.3% | 85,900 |
2023/04/19 | 1,583 | 1,588 | 1,566 | 1,573 | -16 | -1% | 95,100 |
2023/04/18 | 1,581 | 1,591 | 1,577 | 1,589 | +17 | +1.1% | 72,700 |
2023/04/17 | 1,568 | 1,574 | 1,563 | 1,572 | +8 | +0.5% | 78,400 |
2023/04/14 | 1,580 | 1,585 | 1,563 | 1,564 | -4 | -0.3% | 119,000 |
2023/04/13 | 1,551 | 1,568 | 1,547 | 1,568 | +9 | +0.6% | 69,900 |
2023/04/12 | 1,565 | 1,567 | 1,555 | 1,559 | +2 | +0.1% | 80,300 |
2023/04/11 | 1,559 | 1,565 | 1,551 | 1,557 | -1 | -0.1% | 84,800 |
2023/04/10 | 1,558 | 1,564 | 1,548 | 1,558 | +4 | +0.3% | 74,500 |
2023/04/07 | 1,554 | 1,563 | 1,553 | 1,554 | -7 | -0.4% | 54,400 |
2023/04/06 | 1,556 | 1,566 | 1,552 | 1,561 | -5 | -0.3% | 89,700 |
2023/04/05 | 1,582 | 1,589 | 1,562 | 1,566 | -26 | -1.6% | 108,600 |
2023/04/04 | 1,594 | 1,601 | 1,581 | 1,592 | +2 | +0.1% | 78,300 |
2023/04/03 | 1,581 | 1,595 | 1,570 | 1,590 | +27 | +1.7% | 123,100 |
2023/03/31 | 1,568 | 1,570 | 1,552 | 1,563 | +2 | +0.1% | 71,200 |
2023/03/30 | 1,566 | 1,571 | 1,555 | 1,561 | -23 | -1.5% | 63,400 |
2023/03/29 | 1,557 | 1,586 | 1,550 | 1,584 | +32 | +2.1% | 137,800 |
2023/03/28 | 1,568 | 1,574 | 1,550 | 1,552 | -11 | -0.7% | 54,100 |
2023/03/27 | 1,565 | 1,572 | 1,561 | 1,563 | +8 | +0.5% | 70,200 |
2023/03/24 | 1,548 | 1,561 | 1,540 | 1,555 | +4 | +0.3% | 53,500 |
2023/03/23 | 1,550 | 1,551 | 1,534 | 1,551 | -9 | -0.6% | 93,800 |
2023/03/22 | 1,580 | 1,583 | 1,560 | 1,560 | ±0 | ±0% | 76,800 |
2023/03/20 | 1,591 | 1,594 | 1,560 | 1,560 | -46 | -2.9% | 73,100 |
2023/03/17 | 1,608 | 1,612 | 1,593 | 1,606 | +12 | +0.8% | 104,900 |
2023/03/16 | 1,561 | 1,595 | 1,561 | 1,594 | +1 | +0.1% | 102,100 |
2023/03/15 | 1,597 | 1,600 | 1,587 | 1,593 | +10 | +0.6% | 84,200 |
2023/03/14 | 1,583 | 1,594 | 1,566 | 1,583 | -18 | -1.1% | 129,400 |
2023/03/13 | 1,608 | 1,610 | 1,594 | 1,601 | -24 | -1.5% | 65,400 |
2023/03/10 | 1,617 | 1,634 | 1,615 | 1,625 | -11 | -0.7% | 93,100 |
2023/03/09 | 1,625 | 1,636 | 1,617 | 1,636 | +20 | +1.2% | 83,100 |
501~
550
件表示中 / 6969件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
栄研化 | 202,000円 | +4.1% | -3.1% | 2.87% | 17.59倍 | 1.53倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
杏林製薬 | 149,000円 | -2.4% | -52.3% | 3.83% | 17.83倍 | 0.63倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ネクセラファーマ | 92,600円 | +20.3% | - | 0.00% | 164.18倍 | 1.22倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
JCRファーマ | 57,000円 | +14.3% | - | 3.51% | 23.15倍 | 1.48倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
あすかHD | 231,100円 | +16.9% | +33.2% | 2.38% | 12.61倍 | 1.00倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
市場注目の銘柄
チャート関連のコラム